JP2023501308A5 - - Google Patents
Info
- Publication number
- JP2023501308A5 JP2023501308A5 JP2022525870A JP2022525870A JP2023501308A5 JP 2023501308 A5 JP2023501308 A5 JP 2023501308A5 JP 2022525870 A JP2022525870 A JP 2022525870A JP 2022525870 A JP2022525870 A JP 2022525870A JP 2023501308 A5 JP2023501308 A5 JP 2023501308A5
- Authority
- JP
- Japan
- Prior art keywords
- amh
- seq
- amino acid
- acid residues
- analog according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019904097 | 2019-10-30 | ||
| AU2019904097A AU2019904097A0 (en) | 2019-10-30 | Anti-mullerian hormone polypeptides | |
| PCT/AU2020/051187 WO2021081601A1 (en) | 2019-10-30 | 2020-10-30 | Anti-mullerian hormone polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023501308A JP2023501308A (ja) | 2023-01-18 |
| JP2023501308A5 true JP2023501308A5 (enExample) | 2023-11-09 |
Family
ID=75714709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525870A Pending JP2023501308A (ja) | 2019-10-30 | 2020-10-30 | 抗ミュラー管ホルモンポリペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220411477A1 (enExample) |
| EP (1) | EP4051699A4 (enExample) |
| JP (1) | JP2023501308A (enExample) |
| KR (1) | KR20220155980A (enExample) |
| CN (1) | CN114945588A (enExample) |
| AU (1) | AU2020373165A1 (enExample) |
| CA (1) | CA3156607A1 (enExample) |
| WO (1) | WO2021081601A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025049960A1 (en) * | 2023-08-30 | 2025-03-06 | University Of Cincinnati | Enhancing the production of anti-mullerian hormone through modification of its prodomain |
| WO2025085972A1 (en) * | 2023-10-27 | 2025-05-01 | Monash University | Anti-mullerian hormone agonists |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9289492B2 (en) * | 2007-07-17 | 2016-03-22 | The General Hospital Corporation | Collecting ovarian cancer stem cells from ovarian cancer cells |
| WO2010017290A1 (en) * | 2008-08-05 | 2010-02-11 | The Trustees Of Columbia University In The City Of New York | Müllerian inhibiting substance (mis) analogues |
| WO2012166712A1 (en) * | 2011-05-27 | 2012-12-06 | Fox Chase Cancer Center | Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies |
| HK1215259A1 (zh) * | 2012-11-09 | 2016-08-19 | Ansh Labs Llc | 檢測抗苗勒管激素的同種型的抗體組合物及免疫測定方法 |
| WO2017088027A1 (en) * | 2015-11-26 | 2017-06-01 | Prince Henry's Institute Of Medical Research Trading As The Hudson Institute Of Medical Research | Inhibin analogs |
| EP3257867A1 (fr) * | 2016-06-17 | 2017-12-20 | Biomérieux | Procédé de préparation d'anticorps anti-amh et leurs utilisations |
| US11518793B2 (en) * | 2016-12-14 | 2022-12-06 | The General Hospital Corporation | Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation |
| WO2018148649A1 (en) * | 2017-02-10 | 2018-08-16 | The Institute For Cancer Research D/B/A | Chimera of bone morphogenic protein 2 and the müllerian-inhibiting substance type ii receptor binding region of mullerian-inhibiting substance |
-
2020
- 2020-10-30 CA CA3156607A patent/CA3156607A1/en active Pending
- 2020-10-30 AU AU2020373165A patent/AU2020373165A1/en not_active Abandoned
- 2020-10-30 EP EP20880602.6A patent/EP4051699A4/en active Pending
- 2020-10-30 CN CN202080090934.2A patent/CN114945588A/zh active Pending
- 2020-10-30 JP JP2022525870A patent/JP2023501308A/ja active Pending
- 2020-10-30 KR KR1020227018295A patent/KR20220155980A/ko not_active Ceased
- 2020-10-30 WO PCT/AU2020/051187 patent/WO2021081601A1/en not_active Ceased
- 2020-10-30 US US17/773,529 patent/US20220411477A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101553243B (zh) | 组织损伤修复中的基质细胞衍生因子1的蛋白酶抗性突变体 | |
| CN101622271B (zh) | 抗微生物肽 | |
| ES2306483T5 (es) | Prote�?na inhibidora de la ruta de señalización de wnt. | |
| JP2023528207A5 (enExample) | ||
| KR100610389B1 (ko) | 조눌린의 펩타이드 길항제와 그 사용 방법 | |
| JP2023518596A5 (enExample) | ||
| CN101370821B (zh) | 新型肽及其用途 | |
| HU217843B (hu) | Paratiroid hormon (PTH) rokon polipeptidek, eljárások ezek előállítására és az ezeket tartalmazó gyógyszerek osteoporosis kezelésére | |
| CA2230885A1 (en) | Compounds and methods for immunotherapy and diagnosis of tuberculosis | |
| CA2370289A1 (en) | Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides | |
| JP2023501308A5 (enExample) | ||
| JPWO2019156137A5 (enExample) | ||
| JPS59156284A (ja) | ヒト−レラキシンｈ２遺伝子 | |
| JP2015504052A5 (enExample) | ||
| JP2002514418A5 (enExample) | ||
| JP2004538320A5 (enExample) | ||
| Rahman et al. | Molecular cloning and nucleotide sequence of leukocidin F-component gene (lukF) from methicillin resistant Staphylococcus aureus | |
| CN107011430B (zh) | 一种具有生物学活性的截短的生长分化因子11及其制备方法 | |
| CN101671396A (zh) | 与胶原蛋白特异结合的血管内皮生长因子及其应用 | |
| JP2025512749A5 (enExample) | ||
| JP2020127419A5 (enExample) | ||
| RU2010120571A (ru) | Тимус-специфический белок | |
| CN116262781A (zh) | 抗菌肽defensin衍生物及其原核表达方法与应用 | |
| JP2001515720A (ja) | β−デフェンシン | |
| CN105073125A (zh) | 创伤治愈剂 |